R.A. Du Pasquier

Discipline

Psychologie (5) Sociologie (1)

Type de document

Articles (19) Recensions (3)

Co-auteur

Date

Source

Mot-clé

Patients (15) Patients (15) Human beings (12) Multiple sclerosis (10) Treatment (9) thérapie (8) adulte (8) Therapeutics (8) adulte (8) maladie (7) cohorte (7) maladie (7) temps (durée) (6) spectacle (6) taux (6) Time (6) Diseases (6) Brain (6) Older people (6) cerveau (6) Control (5) Diseases (5) Methods (5) Methods (5) Disabilities (5) puits (4) infection (4) effet (4) jeune (4) Inflammation (4)

Documents écrit par R.A. Du Pasquier (19) | parle de R.A. Du Pasquier (0)

Association of Spinal Cord Atrophy and Brain Paramagnetic Rim Lesions With Progression Independent of Relapse Activity in People With MS.
A. Cagol et al. (9 janv. 2024)
Ocrelizumab Impairs the Phenotype and Function of Memory CD8+ T Cells: A 1-Year Longitudinal Study in Patients With Multiple Sclerosis.
A. Mathias et al.
CCR5 Blockade in Inflammatory PML and PML-IRIS Associated With Chronic Inflammatory Diseases' Treatments.
R. Bernard-Valnet et al.
Encephalopathies Associated With Severe COVID-19 Present Neurovascular Unit Alterations Without Evidence for Strong Neuroinflammation.
R. Bernard-Valnet et al.
Effect of national HIV testing recommendations and local interventions on HIV testing practices in a Swiss university hospital: a retrospective analysis between 2012 and 2015.
T. Lazzarino et al. (3 oct. 2018)
Rivastigmine decreases brain damage in HIV patients with mild cognitive deficits.
G. Perrotta et al.
Interleukin-22 is increased in multiple sclerosis patients and targets astrocytes.
G. Perriard et al. (2015)
Immunological mechanism of action and clinical profile of disease-modifying treatments in multiple sclerosis.
R.A. Du Pasquier et al. (2014)
MOBP-specific cellular immune responses are weaker than MOG-specific cellular immune responses in patients with multiple sclerosis and healthy subjects.
S. Jilek et al. (2013)
Micro-Structural Brain Alterations in Aviremic HIV+ Patients with Minor Neurocognitive Disorders: A Multi-Contrast Study at High Field.
C. Granziera et al. (2013)
HIV Testing Practices by Clinical Service before and after Revised Testing Guidelines in a Swiss University Hospital
O. Hugli et al. (2012)
Multiple sclerosis decreases explicit counterfactual processing and risk taking in decision making.
S. Simioni et al. (2012)
Type I IFN-mediated regulation of IL-1 production in inflammatory disorders.
K. Ludigs et al. (2012)
HIV-associated neurocognitive disorders (HAND): a changing pattern
S. Simioni et al. (2011)
Rituximab is successful in an HIV-positive patient with MuSK myasthenia gravis.
T. Kuntzer et al. (2011)
Immune responses to JC virus in patients with multiple sclerosis treated with natalizumab: a cross-sectional and longitudinal study.
S. Jilek et al. (2010)
Progressive decline of decision-making performances during multiple sclerosis.
S. Simioni et al. (2009)
Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis
S. Jilek et al. (2008)
Inaugural description of Cogan syndrome in an HIV-infected person.
J. Kleeberg et al. (2008)